Will Medicare cover Alzheimer’s drugs like Aduhelm? That decision-making process is underway. This week, the U.S. government embarked on the formal review process to…
Image: Aduhelm, Biogen/AP. The head of the FDA, Dr. Janet Woodcock, calls for investigation into the agency’s own controversial approval of Biogen’s Aduhelm, the…
Image: Lynn Casteel Harper, by Travis Tanay Lynn Casteel Harper, author of On Vanishing: Mortality, Dementia, and What It Means to Disappear (Catapult, 2020) and minister of…
This week, on the heels of Aduhelm’s FDA approval, the agency granted breakthrough status to two more prospective new Alzheimer’s treatments, Eli Lilly &…
After much controversy, more resignations in protest against the FDA accelerated approval of Biogen’s Alzheimer’s drug Aduhelm (aducanumab). In a bold act of protest…
Looking for answers about Alzheimer’s treatment Aduhelm (generic name aducanumab)? Here’s a primer on what it is, what it does, and more, according to…
As an aducanumab trial participant, Phil Gutis, a reporter with early-stage Alzheimer’s, was part of Aduhelm’s journey to FDA approval. Doctors can soon start…